Back
Nephros, Inc. 10K Form
Sell
17
NEPH
Nephros, Inc.
Last Price:
$2.87
Seasonality Move:
28.43%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-02-27 | 10K | NEPH/Nephros, Inc. Annual |
| 2019-11-06 | 10Q | NEPH/Nephros, Inc. Quarterly |
| 2019-08-07 | 10Q | NEPH/Nephros, Inc. Quarterly |
| 2019-05-08 | 10Q | NEPH/Nephros, Inc. Quarterly |
| 2019-03-12 | 10K | NEPH/Nephros, Inc. Annual |
| 2018-11-08 | 10Q | NEPH/Nephros, Inc. Quarterly |
Receive NEPH News And Ratings
See the #1 stock for the next 7 days that we like better than NEPH
NEPH Financial Statistics
Sales & Book Value
| Annual Sales: | $18.8M |
|---|---|
| Cash Flow: | $230K |
| Price / Cash Flow: | 18.47 |
| Annual Sales: | $0.96 |
| Price / Book: | 2.9 |
Profitability
| EPS (TTM): | 0.11050 |
|---|---|
| Net Income (TTM): | $1.2M |
| Gross Margin: | $11.5M |
| Return on Equity: | 12.52% |
| Return on Assets: | 9.61% |
Nephros, Inc. Earnings Forecast
Key Nephros, Inc. Financial Ratios
-
The Gross Profit Margin over the past 26 years for NEPH is 61.13%.
-
The Selling, General & Administrative Expenses for NEPH have been equal to 47.90% of Gross Profit Margin.
-
The Research & Development expenses have been 7.13% of Revenue.
-
The Interest Expense is 0.08% of Operating Income.
-
The Net Earning history of NEPH is 6.35% of Total Revenues.
-
Per Share Earnings over the last 26 years have been positive in 15 years.
Nephros, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Machinery |
| Sector: | Industrials |
| Current Symbol: | NEPH |
| CUSIP: | 640671 |
| Website: | nephros.com |
Debt
| Debt-to-Equity Ratio: | 0.1 |
|---|---|
| Current Ratio: | 4.06 |
| Quick Ratio: | 2.82 |
Price-to-Earnings
| Trailing P/E Ratio: | 25.55 |
|---|---|
| Forward P/E Ratio: | 21.41 |
NEPH Technical Analysis vs Fundamental Analysis
Sell
17
Nephros, Inc. (NEPH)
is a Sell
Is Nephros, Inc. a Buy or a Sell?
-
Nephros, Inc. stock is rated a SellThe current Nephros, Inc. [NEPH] share price is $2.87. The Score for NEPH is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.